We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.27%
2 Consumer Discretionary 9.91%
3 Healthcare 7.11%
4 Financials 6.94%
5 Communication Services 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KGC icon
1626
PUT
Kinross Gold
KGC
$27.8B
$7.4M 0.01%
1,380,500
+707,500
+105% +$4.24M
AAC
1627
DELISTED
Ares Acquisition Corporation
AAC
$7.4M 0.01%
759,510
+509,510
+204% +$4.96M
STAA icon
1628
PUT
STAAR Surgical
STAA
$1.1B
$7.39M 0.01%
57,500
+15,400
+37% +$2.16M
AUPH icon
1629
Aurinia Pharmaceuticals
AUPH
$1.96B
$7.39M 0.01%
333,869
+294,258
+743% +$4.67M
HLGN
1630
DELISTED
Heliogen, Inc.
HLGN
$7.35M 0.01%
21,170
+13,551
+178% +$4.69M
LDTC
1631
DELISTED
LeddarTech
LDTC
$7.34M 0.01%
1,504,852
+533,182
+55% +$2.59M
ARKO icon
1632
ARKO Corp
ARKO
$911M
$7.34M 0.01%
+726,985
New +$6.55M
DECK icon
1633
Deckers Outdoor
DECK
$13.8B
$7.34M 0.01%
122,328
+70,332
+135% +$4.82M
AMT icon
1634
PUT
American Tower
AMT
$82.4B
$7.33M 0.01%
27,600
-15,900
-37% -$4.53M
SVC
1635
Service Properties Trust
SVC
$1.06B
$7.33M 0.01%
130,697
+16,797
+15% +$955K
TRMB icon
1636
Trimble
TRMB
$13.5B
$7.32M 0.01%
88,998
-84,975
-49% -$7.46M
HIII
1637
DELISTED
Hudson Executive Investment Corp. III Class A Common Stock
HIII
$7.32M 0.01%
751,981
+551,981
+276% +$5.37M
YETI icon
1638
Yeti Holdings
YETI
$3.91B
$7.31M 0.01%
85,264
+14,343
+20% +$1.39M
ISLE
1639
DELISTED
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
$7.3M 0.01%
742,245
+475,629
+178% +$4.64M
EPC icon
1640
Edgewell Personal Care
EPC
$1.33B
$7.29M 0.01%
200,776
+43,558
+28% +$1.79M
FCAX
1641
DELISTED
Fortress Capital Acquisition Corp.
FCAX
$7.28M 0.01%
744,629
+254,667
+52% +$2.49M
VIR icon
1642
Vir Biotechnology
VIR
$1.45B
$7.27M 0.01%
167,126
-52,102
-24% -$2.26M
OHPA
1643
DELISTED
Orion Acquisition Corp. Class A common stock
OHPA
$7.27M 0.01%
749,717
+674,717
+900% +$6.57M
TPTX
1644
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$7.27M 0.01%
109,418
-19,601
-15% -$1.4M
CRZN
1645
DELISTED
Corazon Capital V838 Monoceros Corp Class A Ordinary Shares
CRZN
$7.26M 0.01%
750,000
+598,791
+396% +$5.81M
PXLW icon
1646
Pixelworks
PXLW
$36.9M
$7.24M 0.01%
126,299
+113,458
+884% +$5.76M
PAGS icon
1647
CALL
PagSeguro Digital
PAGS
$2.64B
$7.24M 0.01%
140,000
BHE icon
1648
Benchmark Electronics
BHE
$2.69B
$7.23M 0.01%
270,711
-15,537
-5% -$412K
NOC icon
1649
CALL
Northrop Grumman
NOC
$79B
$7.2M 0.01%
20,000
-700
-3% -$253K
LKFT
1650
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$7.2M 0.01%
136,801
+69,710
+104% +$4.14M

Similar funds

D.E. Shaw & Co's Q3 2021 Portfolio in Review

As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.

  • D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
  • D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.